2Liao SL, Kao SC, Hou PK, et al. Results of radiotherapy for orbital and adnexal lymphoma. Orbit, 2002, 21:117-123.
3Hasegawa M, Kojima M, Shioya M, et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys, 2003, 57:172-176.
4Auw-Haedrich C, Couplaud SE, Kapp A, et al. Long tern outcome of ocular andexal lymphoma subtyped according to the REAL classification. Revised European and American lymphoma. Br J Ophthalmol,2001, 85:63-69.
5Baldini, Blini M, Guffanti A, Fossati V,et al. Treatment and prognosis in a series of primary extranodal lyphomas of the ocular adnexa.Ann Oncol, 1998, 9:779-781.
6Esik O, Ikeda H, Mukai K, et al .A retrospective analysis of different modalities for treatment of primary ortibal non-Hodgkin's lymphomas. Radiother Oncol,1996, 38:13-18.
7Lee SW, Suh CO, Kim GE,et al. Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol, 2002, 25: 261-265.
8Liao SL,Kao SC, Hou PK,et al.Resulis of radiotherapy for orbital and adnexal lymphoma. Orbit,2002, 21:117-123.
9Hasegawa M, Kojima M, Shioya M, et al. Treament results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys, 2003, 57:172-176.
10Jacobs D, Galetta S. Dignosis and management of orbit pseudotumor.Curr Opin Ophthalmol, 2002, 13:347-351.
1Oberlin O, Rey A,Anders J. Treatment af orbital dmbdomyosarcoma: survival and late effects of treatnnt-resuhs of an intexrmtion workshop [J] .J Clin 0ncol,2001,19:197-204.
2Taheri-Kadkhoda Z, Pettersson N, Bjork-Eriksson T, et al. Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study. Br J Radiol, 2008, 81: 397-405.
3Gerber DE, Chan TA. Recent advances in radiation therapy. Am Fam Physician, 2008, 78 : 1254-1262.
4Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol, 2009, 54 : 545-568.
5Bangalore M, Matthews S, Suntharalingam M. Recent advances in radiation therapy for head and neck cancer. ORL J Otorhinolaryngol Relat Spec, 2007, 69: 1-12.
6Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Exp Ophthalmol, 2008, 36: 78-89.
7Pica A, Moeckli R, Balmer A, et al. Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromuhileaf collimator as second-line or salvage treatment after chemotherapy. Int J Radiation Oncol Biol Phys, 2011, 81 : 1380-1386.
8Krasin M J, Crawford BT, Zhu Y, et al. Intensity-modulated radiation therapy for children with intraocular retinoblastoma: potential sparing of the bony orbit. Clin Oncol (R Coll Radiol), 2004, 16: 215-222.
9Reisner ML, Viegas CM, Grazziotin RZ, et al. Retinoblastoma-- comparative analysis of external radiotherapy techniques, including an IMRT technique. Int J Radiat Oncol Biol Phys, 2007, 67: 933-941.
10Lee CT, Bihon SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?. Int J Radiat Oncol Biol Phys, 2005,63 : 362-372.
